• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNAM-1 配体在 Ag 刺激的 T 淋巴细胞上的表达是由 ROS 依赖性 DNA 损伤反应激活介导的:与 NK-T 细胞相互作用有关。

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.

机构信息

Department of Molecular Medicine, Sapienza University of Rome, Italy.

出版信息

Blood. 2011 May 5;117(18):4778-86. doi: 10.1182/blood-2010-08-300954. Epub 2011 Mar 15.

DOI:10.1182/blood-2010-08-300954
PMID:21406724
Abstract

An important role for natural killer (NK) cells in the regulation of T-cell responses is emerging, although the receptor pairs regulating the NK-T-cell interaction have still not been identified. We found that superantigen-stimulated T cells express Nectin-2 (CD112) and poliovirus receptor (PVR; CD155), the ligands of the activating NK receptor DNAX accessory molecule-1 (DNAM-1; CD226). Interestingly, only PVR was present at the T cell surface, particularly on cells in the S and G(2)/M phases of the cell cycle. The up-regulation of PVR expression involves DNA-damage response (DDR)-dependent pathways, because we found that pharmacologic inhibition of ATM and ATR kinases reduced PVR expression and that PVR was almost exclusively induced on cells expressing the DDR marker γH2AX. Oxidative stress contributed to DDR activation, and our results showed impaired PVR levels in the presence of the reactive oxygen species (ROS) scavenger N-acetyl-cysteine (NAC), being monocytes the main ROS source needed for optimal PVR expression on activated T cells. Interestingly, in accordance with ligand expression, NK cells lysed allogeneic proliferating more efficiently than nonproliferating T lymphocytes, with a mechanism requiring the cooperation between DNAM-1 and NKG2D. These results could contribute to unraveling the role of NK cells in the down-regulation of T-cell responses in physiologic and pathologic processes such as autoimmunity or GVHD.

摘要

自然杀伤 (NK) 细胞在调节 T 细胞反应中起着重要作用,尽管调节 NK-T 细胞相互作用的受体对仍未被确定。我们发现超抗原刺激的 T 细胞表达 Nectin-2(CD112)和脊髓灰质炎病毒受体(PVR;CD155),这是激活 NK 受体 DNAX 辅助分子-1(DNAM-1;CD226)的配体。有趣的是,只有 PVR 存在于 T 细胞表面,特别是在细胞周期的 S 和 G2/M 期的细胞上。PVR 表达的上调涉及 DNA 损伤反应 (DDR) 依赖途径,因为我们发现,ATM 和 ATR 激酶的药理学抑制降低了 PVR 的表达,并且 PVR 几乎仅在表达 DDR 标志物 γH2AX 的细胞上诱导。氧化应激有助于 DDR 激活,我们的结果表明,在活性氧 (ROS) 清除剂 N-乙酰半胱氨酸 (NAC) 的存在下,PVR 水平受损,并且单核细胞是激活的 T 细胞上最佳 PVR 表达所需的主要 ROS 来源。有趣的是,与配体表达一致,NK 细胞裂解同种异体增殖的 T 淋巴细胞比非增殖的 T 淋巴细胞更有效,其机制需要 DNAM-1 和 NKG2D 之间的合作。这些结果可能有助于揭示 NK 细胞在生理和病理过程(如自身免疫或移植物抗宿主病)中下调 T 细胞反应中的作用。

相似文献

1
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.DNAM-1 配体在 Ag 刺激的 T 淋巴细胞上的表达是由 ROS 依赖性 DNA 损伤反应激活介导的:与 NK-T 细胞相互作用有关。
Blood. 2011 May 5;117(18):4778-86. doi: 10.1182/blood-2010-08-300954. Epub 2011 Mar 15.
2
Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).DNAX辅助分子-1(CD226)与其配体脊髓灰质炎病毒受体(CD155)和nectin-2(PRR-2/CD112)相互作用的功能特性
Int Immunol. 2004 Apr;16(4):533-8. doi: 10.1093/intimm/dxh059.
3
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.人巨细胞病毒即刻早期蛋白IE1和IE2在MICA和PVR/CD155表达转录调控中的不同作用
J Immunol. 2016 Nov 15;197(10):4066-4078. doi: 10.4049/jimmunol.1502527. Epub 2016 Oct 12.
4
Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1.活性氧和DNA损伤反应依赖性自然杀伤细胞激活配体上调发生在转录水平,并且需要转录因子E2F1。
J Immunol. 2014 Jul 15;193(2):950-60. doi: 10.4049/jimmunol.1400271. Epub 2014 Jun 9.
5
Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.通过 DNAM-1 和 NKG2D 增强自然杀伤细胞介导的肉瘤靶向作用。
Front Immunol. 2020 Jan 28;11:40. doi: 10.3389/fimmu.2020.00040. eCollection 2020.
6
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.治疗药物通过ATM-ATR依赖性上调多发性骨髓瘤细胞上的DNAM-1和NKG2D配体,导致自然杀伤细胞(NK细胞)易感性增强,并与衰老表型相关。
Blood. 2009 Apr 9;113(15):3503-11. doi: 10.1182/blood-2008-08-173914. Epub 2008 Dec 19.
7
Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.一氧化氮供体增加多发性骨髓瘤细胞中PVR/CD155 DNAM-1配体的表达:DNA损伤反应激活的作用
BMC Cancer. 2015 Jan 22;15:17. doi: 10.1186/s12885-015-1023-5.
8
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.自然杀伤细胞介导的骨髓瘤细胞杀伤中对DNAX辅助分子-1(DNAM-1)、自然杀伤细胞激活受体2D(NKG2D)和自然杀伤细胞p46受体(NKp46)的需求。
Cancer Res. 2007 Sep 15;67(18):8444-9. doi: 10.1158/0008-5472.CAN-06-4230.
9
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.作为人类DNAM-1(CD226)激活受体配体的PVR(CD155)和Nectin-2(CD112):参与肿瘤细胞裂解。
Mol Immunol. 2005 Feb;42(4):463-9. doi: 10.1016/j.molimm.2004.07.028.
10
DNAM-1 and PVR regulate monocyte migration through endothelial junctions.DNAX辅助分子-1(DNAM-1)和脊髓灰质炎病毒受体(PVR)通过内皮连接调节单核细胞迁移。
J Exp Med. 2004 May 17;199(10):1331-41. doi: 10.1084/jem.20032206. Epub 2004 May 10.

引用本文的文献

1
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.四重腺嘌呤碱基编辑的同种异体嵌合抗原受体T细胞优于CRISPR/Cas9核酸酶工程改造的T细胞。
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2427216122. doi: 10.1073/pnas.2427216122. Epub 2025 May 5.
2
Natural killer cells in multiple sclerosis: foe or friends?多发性硬化症中的自然杀伤细胞:敌还是友?
Front Cell Neurosci. 2025 Apr 4;19:1500770. doi: 10.3389/fncel.2025.1500770. eCollection 2025.
3
Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.
使用扩增的非基因改造自体自然杀伤细胞(SNK01)治疗阿尔茨海默病受试者:一项I期研究。
Alzheimers Res Ther. 2025 Feb 12;17(1):40. doi: 10.1186/s13195-025-01681-2.
4
Germline natural killer cell receptors modulating the T cell response.胚系自然杀伤细胞受体调节 T 细胞反应。
Front Immunol. 2024 Nov 4;15:1477991. doi: 10.3389/fimmu.2024.1477991. eCollection 2024.
5
The basic biology of NK cells and its application in tumor immunotherapy.自然杀伤细胞的基础生物学及其在肿瘤免疫治疗中的应用。
Front Immunol. 2024 Aug 16;15:1420205. doi: 10.3389/fimmu.2024.1420205. eCollection 2024.
6
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial.在骨髓瘤中进行 TIGIT-LAG3 阻断后的临床反应和通路特异性相关性:MyCheckpoint 随机临床试验。
Nat Cancer. 2024 Oct;5(10):1459-1464. doi: 10.1038/s43018-024-00818-w. Epub 2024 Aug 26.
7
The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy.Nectin 家族配体 PVRL2 和 PVR 在癌症免疫和免疫治疗中的作用。
Front Immunol. 2024 Aug 2;15:1441730. doi: 10.3389/fimmu.2024.1441730. eCollection 2024.
8
Poliovirus receptor inhibition in breast cancer cells induces antitumor immunity via T cell activation.抑制乳腺癌细胞中的脊髓灰质炎病毒受体可通过激活T细胞诱导抗肿瘤免疫。
Am J Cancer Res. 2023 Dec 15;13(12):5966-5980. eCollection 2023.
9
Killer instincts: natural killer cells as multifactorial cancer immunotherapy.杀手本能:自然杀伤细胞作为多因素癌症免疫疗法。
Front Immunol. 2023 Nov 28;14:1269614. doi: 10.3389/fimmu.2023.1269614. eCollection 2023.
10
Balancing act: the complex role of NK cells in immune regulation.平衡之举:NK 细胞在免疫调节中的复杂作用。
Front Immunol. 2023 Nov 2;14:1275028. doi: 10.3389/fimmu.2023.1275028. eCollection 2023.